Asthma is a chronic lung disease, which makes breathing difficult. When the symptoms suddenly get worse it results in an asthma attack. As of now, there's no cure for asthma, however, with the proper treatment plan its symptoms can easily control. In some cases, it can make trouble while talking or doing physical activities.
DelveInsight's "Asthma Market Insights, Epidemiology, and Market Forecast 2030" report delivers an in-depth understanding of the Asthma Market, historical and forecasted epidemiology, the pipeline insight as well as the Asthma market size and shares analysis in the seven major markets (7MM) (i.e. the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Asthma Market Key Facts
According to the CDC, about 6 million children in the US ages 0-17 years have asthma. More than half of all children with asthma had 1 or more attacks in 2016.
As per the WHO, It was estimated that more than 339 million people had Asthma globally in 2016. (1) It is a common disease among children.
Asthma Market Trends and Share Analysis
The Asthma market analysis section of the report helps to build the detailed comprehension of the historic, current and forecasted Asthma market trends and growth by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Asthma market size and shares of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
The Asthma epidemiology section covers insights about historical and current Asthma patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Asthma Pipeline Analysis and Key Companies
The Asthma Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Asthma market or expected to get launched in the market during the study period. The analysis covers Asthma market uptake by drugs; patient uptake by therapies; and sales of each drug.
Some of the key Companies in the Asthma Treatment Market include:
AstraZeneca
Boehringer Ingelheim
Sumitomo Dainippon
Novartis AG
Mylan N.V.
GlaxoSmithKline
Teva Pharmaceutica
Merck
Regeneron
And many others.
For more details on Asthma Market Trends and Share Analysis, visit:
https://www.delveinsight.com/report-store/asthma-market